Bionyra Pharma
Bionyra Pharma develops biologic therapies for severe immunological and inflammatory diseases.
$165MSeries A
Role not disclosedActivity from announced rounds
Bionyra Pharma develops biologic therapies for severe immunological and inflammatory diseases.
Generates molecular data for drug development